Physician profile
Daniel Kaufman
NPI 1215171566
$12,989.94
in general payments reported to CMS, 2019-2025
9 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.46 · 2020: $42.65 · 2022: $15.55 · 2023: $143 · 2024: $13K · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $13K · Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $12,539.51 |
| Food and Beverage | $369.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $12,539.51 | 2024 | |
| Abbott Laboratories | $142.79 | 2023 | Xact |
| New World Medical,INC. | $115.43 | 2025 | Streamline, Via360, Ahmed Glaucoma Valve |
| Sun Pharmaceutical Industries INC. | $92.97 | 2025 | |
| Acell, INC. | $25.00 | 2020 | |
| Gc America INC. | $22.46 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.58 | 2024 | Exparel |
| Covidien Lp | $17.65 | 2020 | |
| Galderma Laboratories, L.P. | $15.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.